Go to content

Publications

460 publications

Enter search criteria
Fill in keyword(s) to narrow your search.
Period
You can select a specific type of a publication you are looking for, such as press releases or speeches
Sort by:

  1. Brivaracetam (Briviact®)

    The National Health Care Institute has approved a pharmacotherapeutic report for the medicine brivaracetam (Briviact®), whereby ...

    Report | 23-05-2016

  2. Lumacaftor/ivacaftor (Orkambi®) by Cystic fibrosis

    Based on the GVS criteria, lumacaftor/ivacaftor (Orkambi®) can not be replaced by another drug in the GVS.  The assessment ...

    Report | 13-05-2016

  3. Eculizumab (Soliris®) for the treatment of patients with paroxysmal nocturnal haemogloninuria

    The National Health Care Institute has re-assessed the medicine eculizumab (Soliris®) for the treatment of patients with ...

    Report | 13-05-2016

  4. Levo floxacin (Quinsair®) for the treatment of chronic pulmonary infections due to Pseudomonas aeruginosa

    The National Health Care Institute carried out a marginal assessment of the medicine levofloxacin (Quinsair®), whereby they came ...

    Report | 03-05-2016

  5. Early Intensive Neurorehabilitation of adults with unresponsive wakefulness syndrome or a prolonged minimally conscious state

    This report is a summary of recommendations by the National Health Care Institute. The original text is in Dutch.

    Report | 29-03-2016

  6. Safinamide (Xadago®) for the treatment of adult patients with idiopathic Parkinson's disease

    The National Health Care Institute has approved a pharmacotherapeutic report for the medicine safinamide (Xadago®). They reached ...

    Report | 21-03-2016

  7. Onabotulinum toxin A 100 U in cases of idiopathic overactive bladder

    The National Health Care Institute concluded that treatment with onabotulin toxin A 100 U does comply with the established ...

    Report | 25-02-2016

  8. Ivermectin (Soolantra®) by moderate to severe papulopustulous rosacea

    The National Health Care Institute advises the Minister of Public Health, Welfare and Sport to include ivermectin (Soolantra®) in ...

    Report | 22-02-2016

  9. Eltrombopag (Revolade®) in cases of severe aplastic anaemia

    The National Health Care Institute has approved a pharmacotherapeutic report for the medicine eltrombopag (Revolade®) in cases of ...

    Report | 22-02-2016

  10. Health care in the Netherlands

    The philosophy underpinning the Dutch health care system is based on several more or less universal principles: access to care ...

    Publication | 31-01-2016

Go to